comparemela.com

Latest Breaking News On - Morphosy chief executive officer - Page 1 : comparemela.com

MorphoSys to Host Virtual Investor Call with Key Opinion Leaders Focused on Pelabresib on June 21,

EQS-News: MorphoSys AG / Key word(s): Miscellaneous MorphoSys to Host Virtual Investor Call with Key Opinion Leaders Focused on Pelabresib on June 21, 2023 14.06.2023 / 08:39 CET/CESTThe issuer is solely responsible for the content of this announcement.Media ReleasePlanegg/Munich, Germany, June 14, 2023 MorphoS.

United statesNew yorkTim demuthJean paul kressJulia neugebauerGabriela hobbsJohn mascarenhasEamonn nolanThomas biegiDistribution servicesTisch cancer institute at mount sinaiConstellation pharmaceuticals incProfessor of medicine at harvard medical schoolAdult leukemia programExchange commissionLeukemia service at massachusetts

MorphoSys to Host Virtual Investor Call with Key Opinion Leaders Focused on Pelabresib on June 21, 2023

EQS-News: MorphoSys AG / Key word: Miscellaneous MorphoSys to Host Virtual Investor Call with Key Opinion Leaders Focused on Pelabresib on June 21, 2023 14.06.2023 / 08:39. | June 14, 2023

United statesNew yorkThomas biegiTim demuthJean paul kressJulia neugebauerJohn mascarenhasEamonn nolanGabriela hobbsAdult leukemia programLeukemia service at massachusettsTisch cancer institute at mount sinaiProfessor of medicine at harvard medical schoolConstellation pharmaceuticals incExchange commissionHost virtual investor call

EQS-News: MorphoSys to Host Virtual Investor Call with Key Opinion Leaders Focused on Pelabresib on June 21, 2023 Seite 1

14.06.2023 - EQS-News: MorphoSys AG / Key word(s): Miscellaneous MorphoSys to Host Virtual Investor Call with Key Opinion Leaders Focused on Pelabresib on June 21, 2023 14.06.2023 / 08:39 CET/CEST The issuer is solely responsible for the content of this . Seite 1

New yorkUnited statesJohn mascarenhasTim demuthGabriela hobbsJean paul kressProfessor of medicine at harvard medical schoolLeukemia service at massachusettsTisch cancer institute at mount sinaiAdult leukemia programHost virtual investor callKey opinion leaders focusedMorphosy chief executive officerMorphosy chief researchDevelopment officerTisch cancer institute

vimarsana © 2020. All Rights Reserved.